These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23866760)

  • 21. Age-prioritized use of antivirals during an influenza pandemic.
    Merler S; Ajelli M; Rizzo C
    BMC Infect Dis; 2009 Jul; 9():117. PubMed ID: 19638194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccines and antiviral drugs in pandemic preparedness.
    Monto AS
    Emerg Infect Dis; 2006 Jan; 12(1):55-60. PubMed ID: 16494718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing guidelines for school closure interventions to be used during a future influenza pandemic.
    Halder N; Kelso JK; Milne GJ
    BMC Infect Dis; 2010 Jul; 10():221. PubMed ID: 20659348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Containing pandemic influenza at the source.
    Longini IM; Nizam A; Xu S; Ungchusak K; Hanshaoworakul W; Cummings DA; Halloran ME
    Science; 2005 Aug; 309(5737):1083-7. PubMed ID: 16079251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choice of Antiviral Allocation Scheme for Pandemic Influenza Depends on Strain Transmissibility, Delivery Delay and Stockpile Size.
    Lydeamore M; Bean N; Black AJ; Ross JV
    Bull Math Biol; 2016 Feb; 78(2):293-321. PubMed ID: 26846916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance.
    Davey VJ; Glass RJ; Min HJ; Beyeler WE; Glass LM
    PLoS One; 2008 Jul; 3(7):e2606. PubMed ID: 18596963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing antiviral treatment for seasonal influenza in the USA: a mathematical modeling analysis.
    Yechezkel M; Ndeffo Mbah ML; Yamin D
    BMC Med; 2021 Mar; 19(1):54. PubMed ID: 33641677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, Canada.
    Coleman BL; Hassan K; Green K; Gubbay JB; Katz K; Mazzulli T; McNeil S; Muller M; Powis J; Richardson D; Simor A; ; McGeer AJ
    Antiviral Res; 2017 Apr; 140():158-163. PubMed ID: 28179155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standardizing scenarios to assess the need to respond to an influenza pandemic.
    Meltzer MI; Gambhir M; Atkins CY; Swerdlow DL
    Clin Infect Dis; 2015 May; 60 Suppl 1(Suppl 1):S1-8. PubMed ID: 25878296
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics.
    Halder N; Kelso JK; Milne GJ
    PLoS One; 2011; 6(7):e22087. PubMed ID: 21760957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical distancing reduced the incidence of influenza and supports a favorable impact on SARS-CoV-2 spread in Mexico.
    Murillo-Zamora E; Guzmán-Esquivel J; Sánchez-Piña RA; Cedeño-Laurent G; Delgado-Enciso I; Mendoza-Cano O
    J Infect Dev Ctries; 2020 Sep; 14(9):953-956. PubMed ID: 33031079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral resistance and the control of pandemic influenza.
    Lipsitch M; Cohen T; Murray M; Levin BR
    PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential impact of antiviral drug use during influenza pandemic.
    Gani R; Hughes H; Fleming D; Griffin T; Medlock J; Leach S
    Emerg Infect Dis; 2005 Sep; 11(9):1355-62. PubMed ID: 16229762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
    Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
    PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responding to simulated pandemic influenza in San Antonio, Texas.
    Miller G; Randolph S; Patterson JE
    Infect Control Hosp Epidemiol; 2008 Apr; 29(4):320-6. PubMed ID: 18462144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.
    Lugnér AK; Postma MJ
    Eur J Public Health; 2009 Oct; 19(5):516-20. PubMed ID: 19692550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protecting residential care facilities from pandemic influenza.
    Nuño M; Reichert TA; Chowell G; Gumel AB
    Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10625-30. PubMed ID: 18647829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios.
    Rubinstein H; Marcu A; Yardley L; Michie S
    BMC Public Health; 2015 Feb; 15():190. PubMed ID: 25884522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009.
    Jackson ML; France AM; Hancock K; Lu X; Veguilla V; Sun H; Liu F; Hadler J; Harcourt BH; Esposito DH; Zimmerman CM; Katz JM; Fry AM; Schrag SJ
    Clin Infect Dis; 2011 Sep; 53(5):455-62. PubMed ID: 21844028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context.
    Moss R; McCaw JM; Cheng AC; Hurt AC; McVernon J
    BMC Infect Dis; 2016 Oct; 16(1):552. PubMed ID: 27724915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.